An almost always malignant GLUCAGON-secreting tumor derived from the PANCREATIC ALPHA CELLS. It is characterized by a distinctive migratory ERYTHEMA; WEIGHT LOSS; STOMATITIS; GLOSSITIS; DIABETES MELLITUS; hypoaminoacidemia; and normochromic normocytic ANEMIA.
Phase 2 trials (9)
Phase 1 trials (5)
Organization Involved with Phase 2 Indications (11)
Organization Involved with Phase 1 Indications (1)